| dc.contributor.author | Pehlivan, Sacide | |
| dc.contributor.author | Gürsoy, Savaş | |
| dc.contributor.author | Nursal, Ayşe Feyda | |
| dc.contributor.author | Akaltun, Mazlum Serdar | |
| dc.contributor.author | Özdilli, Kürşat | |
| dc.contributor.author | Pehlivan, Mustafa | |
| dc.date.accessioned | 10.07.201910:49:13 | |
| dc.date.accessioned | 2019-07-10T19:50:19Z | |
| dc.date.available | 10.07.201910:49:13 | |
| dc.date.available | 2019-07-10T19:50:19Z | |
| dc.date.issued | 2018 | en_US |
| dc.identifier.citation | Pehlivan, S., Gürsoy, S., Nursal, A., Akaltun, M., Özdilli, K. ve Pehlivan, M. (2018). Mi196a2 T/C variant as possible predisposal factor for ankylosing spondylitis in a Turkish population. European Biotechnology Congress içinde (S22-S22. ss.). Athens, Greece, April 26-28, 2018. https://dx.doi.org/10.1016/j.jbiotec.2018.06.065 | en_US |
| dc.identifier.issn | 0168-1656 | |
| dc.identifier.issn | 1873-4863 | |
| dc.identifier.uri | https://dx.doi.org/10.1016/j.jbiotec.2018.06.065 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12511/1949 | |
| dc.description | European Biotechnology Congress -- APR 26-28, 2018 -- Athens, GREECE | en_US |
| dc.description | WOS: 000454825900063 | en_US |
| dc.description.abstract | Ankylosing spondylitis (AS) is a chronic inflammatory disorder. Micro RNAs (miRNAs), small noncoding RNA molecules, can function as either oncogenes or tumor suppressor genes. Altered miRNA expression has been implicated in the pathogenesis of several diseases. Therefore, we aimed to explore the effects of miR-196a2 T/C (rs11614913) variant profile on susceptibility to AS in a Turkish population. Blood samples were collected from 78 AS patients and 79 controls. | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Elsevier Science Bv | en_US |
| dc.rights | info:eu-repo/semantics/embargoedAccess | en_US |
| dc.title | Mi196a2 T/C variant as possible predisposal factor for ankylosing spondylitis in a Turkish population | en_US |
| dc.type | conferenceObject | en_US |
| dc.relation.ispartof | European Biotechnology Congress | en_US |
| dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Tıbbi Biyoloji Ana Bilim Dalı | en_US |
| dc.authorid | 0000-0002-7129-5024 | en_US |
| dc.identifier.volume | 280 | en_US |
| dc.identifier.issue | Supplement: S | en_US |
| dc.identifier.startpage | S22 | en_US |
| dc.identifier.endpage | S22 | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| dc.identifier.doi | 10.1016/j.jbiotec.2018.06.065 | en_US |
| dc.identifier.wosquality | Q2 | en_US |
